Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.

DNA and cell biology - 1 Feb 2007

Onen Ilke Hacer, Ekmekci Abdullah, Eroglu Muzaffer, Polat Fazli, Biri Hasan

Abstract excerpt

To date, research has led to the invention of multiple genes and their single nucleotide polymorphisms (SNPs) and environmental factors that influence the prostate cancer (PCa) pathogenesis. Therefore, the genes involved in these pathways are candidates for PCa predisposition. It is thought that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Share to Turkey

Source

Identifiers

PMID: 17328668
DOI: 10.1089/dna.2006.0534

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17328668-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.PMID 17328668Read ↗

Genetic polymorphism in sex hormone metabolism and prostate cancer risk.Semantic proximity Read ↗

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.Semantic proximity Read ↗

Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.Semantic proximity Read ↗

Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.Semantic proximity Read ↗

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.Semantic proximity Read ↗

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition.Semantic proximity Read ↗

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.Semantic proximity Read ↗

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.